News

Mother Jones4m
FDA Approves “Breakthrough” HIV Drug
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
LGBTQ Nation6m
FDA approves twice-a-year HIV prevention drug that could help end the virus worldwide
It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.
FDA approves the world's only twice-a-year shot to prevent HIV
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Health Care Flat as Traders Hedge on Rates -- Health Care Roundup
Health-care companies were flat as traders hedged their bets on the outlook for interest rates. Gilead Sciences ticked down even after it won Food and Drug Administration approval for a highly ...
FDA Approves ‘Breakthough’ Drug to Prevent HIV
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
FDA Approves a Twice-Yearly Shot to Prevent HIV
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
WUNC1h
HIV prevention drug hailed as a 'breakthrough' gets FDA approval
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
Agence France-Presse on MSN1h
US approves Gilead's twice-yearly injection to prevent HIV
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...